Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing-Min Zhou

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Chinese Journal of Integrative Medicine|February 14, 2018
Effect of Kuanxiong Aerosol () on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled TrialQiao-Ning Yang, Rui-Na Bai, Guo-Ju Dong, et al.
Thoracic Cancer|September 19, 2017
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancerYan Sun, Jin Wan Wang, Yong Yu Liu, et al.
Frontiers in Oncology|October 12, 2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung AdenocarcinomaLong-Hua Guo, Ming-Feng Zhang, He-Long Zhang, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Chinese Journal of Integrative Medicine|February 14, 2018
Effect of Kuanxiong Aerosol () on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled TrialQiao-Ning Yang, Rui-Na Bai, Guo-Ju Dong, et al.
Thoracic Cancer|September 19, 2017
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancerYan Sun, Jin Wan Wang, Yong Yu Liu, et al.
Frontiers in Oncology|October 12, 2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung AdenocarcinomaLong-Hua Guo, Ming-Feng Zhang, He-Long Zhang, et al.
Pageof 4